GlassScriptPhysician profile
Meghan M Arnold
NPI 1679887855
$17,602.03
in general payments reported to CMS, 2019-2025
32 companies · $5,375 in 2025
The $5,375 reported for 2025 was more than what 94% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,868 · 2020: $194 · 2021: $1,868 · 2022: $3,909 · 2023: $2,281 · 2024: $1,107 · 2025: $5,375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,627 · Consulting Fee: $3,200 · Travel and Lodging: $1,937.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,626.59 |
| Consulting Fee | $3,200.00 |
| Travel and Lodging | $1,937.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $4,809.10 | 2019-2025 | |
| Maxx Health INC | $4,593.62 | 2024-2025 | Summa Ortho Optossol Compression Device, Summa Ortho Cannulated Screw, Summa Ortho Foot |
| Stryker Corporation | $3,620.68 | 2021-2025 | Augment Injectable, Hoffmann, Gamma |
| Arthrex, INC. | $2,093.00 | 2019 | |
| Wright Medical Technology, INC. | $719.36 | 2019-2020 | |
| Kerecis Limited | $492.00 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| In2bones USA, LLC | $190.02 | 2021-2022 | |
| Abbvie INC. | $138.14 | 2023-2025 | Dalvance |
| Depuy Synthes Sales INC. | $114.88 | 2019-2021 | |
| Ets Wound Care LLC | $88.33 | 2024-2025 | Mirragen Advanced Wound Matrix |
| Treace Medical Concepts, INC. | $72.66 | 2022-2023 | |
| Ossio INC | $66.47 | 2023 | |
| Medtronic, INC. | $63.86 | 2024 | Intellis Adaptivestim |
| Polynovo North America LLC | $60.10 | 2024 | Novosorb Btm |
| Bone Support INC. | $56.92 | 2024 | Ceramentbone Void Filler, Cerament G |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $55.26 | 2025 | Senza |
| Aroa Biosurgery Incorporated | $53.49 | 2025 | |
| Smith+Nephew, INC. | $49.63 | 2024-2025 | Stravix, Grafix Pl |
| Averitas Pharma INC. | $38.63 | 2024 | Qutenza |
| Solventum Corporation | $29.19 | 2025 | Activ.A.C., V.A.C.Instill |
| Abbott Laboratories | $24.23 | 2023 | Proclaim |
| Integra Lifesciences Corporation | $20.14 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Mimedx Group, INC. | $17.92 | 2024 | |
| Nevro Corp. | $17.59 | 2024 | Senza |
| Ermi LLC | $17.28 | 2021 | |
| Acumed LLC | $17.24 | 2025 | Acumed, Innate Implant |
| Ebi, LLC | $16.00 | 2025 | Biomet Ebi Bone Healing System |
| Pacira Therapeutics, INC. | $15.85 | 2019 | |
| Paragon 28, INC. | $12.92 | 2021 | |
| Djo, LLC | $12.82 | 2019 | |
| Cashflow Solutions, LLC | $12.72 | 2023 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Zimmer Biomet Holdings, INC. | $11.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meghan Arnold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.